- Home
- DBVT vs EVM Comparison
DBVT vs EVM Comparison
Compare DBVT & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- EVM
- Stock Information
- Founded
- DBVT 2002
- EVM 2002
- Country
- DBVT France
- EVM United States
- Employees
- DBVT N/A
- EVM N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- EVM Finance/Investors Services
- Sector
- DBVT Health Care
- EVM Finance
- Exchange
- DBVT Nasdaq
- EVM Nasdaq
- Market Cap
- DBVT 239.9M
- EVM 219.2M
- IPO Year
- DBVT N/A
- EVM N/A
- Fundamental
- Price
- DBVT $8.01
- EVM $8.76
- Analyst Decision
- DBVT Buy
- EVM
- Analyst Count
- DBVT 4
- EVM 0
- Target Price
- DBVT $14.81
- EVM N/A
- AVG Volume (30 Days)
- DBVT 102.2K
- EVM 55.8K
- Earning Date
- DBVT 07-29-2025
- EVM 01-01-0001
- Dividend Yield
- DBVT N/A
- EVM 4.01%
- EPS Growth
- DBVT N/A
- EVM N/A
- EPS
- DBVT N/A
- EVM 0.20
- Revenue
- DBVT $3,497,000.00
- EVM N/A
- Revenue This Year
- DBVT $1,700.53
- EVM N/A
- Revenue Next Year
- DBVT $535.67
- EVM N/A
- P/E Ratio
- DBVT N/A
- EVM $47.61
- Revenue Growth
- DBVT N/A
- EVM N/A
- 52 Week Low
- DBVT $2.21
- EVM $7.67
- 52 Week High
- DBVT $12.78
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- DBVT 41.18
- EVM 35.40
- Support Level
- DBVT $8.33
- EVM $8.72
- Resistance Level
- DBVT $9.92
- EVM $8.93
- Average True Range (ATR)
- DBVT 0.86
- EVM 0.08
- MACD
- DBVT -0.34
- EVM -0.02
- Stochastic Oscillator
- DBVT 1.48
- EVM 11.43
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.